Send PM
Followers 157
Posts 21124
Boards Moderated 16
Alias Born 04/03/2002

Re: None

Thursday, 03/31/2022 2:09:31 PM

Thursday, March 31, 2022 2:09:31 PM

Post# of 294402
$SPRJ - News on success and growth plans with company's rejuvenation and anti-aging based business plans:

Springs Rejuvenation Inc. Provides Shareholder Update
March 24, 2022 (Globe Newswire)

Springs Rejuvenation Inc. (OTC Pink: SPRJ) is pleased to provide a shareholder update.

Everett Dickson, Springs Rejuvenation CEO, stated, "We are delighted by the progress we have made since completing the merger between Avra, Inc (AVRN) and Springs Rejuvenation, LLC. We've spent the last year completing the steps required to become a new public company, expanding the customer base and opening new locations. We adopted a number of the policies and procedures required to be compliant in all facets of the business. Most importantly, we are excited to assist people in their efforts of having a healthy life by offering stem cell therapy.

Key Business Highlights:

"We believe in the short time since Springs Rejuvenation has been a public company, we have expanded our operations, and implemented new marketing efforts in accordance with our initial business plan. While I am proud of all of our accomplishments and the efforts by our people and partners, I am extremely excited in the amount of time it took us to get our Ft Lauderdale and new Atlanta clinics opened. Both locations were patient ready within 6-weeks after we signed the leases. These will become models both for budgeting and duration as we continue to expand across the country. We are excited by the opportunities that are presenting themselves as we continue to establish new partnerships and locations throughout the U.S.," concluded Mr. Dickson.

About Springs Rejuvenation, Inc.

At Springs Rejuvenation specializes in regenerative medicine and anti-aging research. Our mission is to provide patients with individualized, state-of-the-art treatment, returning each patient to their natural mobility as quickly as possible. With the goal of addressing the root cause of your pain, rather than just masking it. We want to help you achieve whole body health and rejuvenation, which will help you feel stronger, improve mood, look younger, heal faster and perform at the optimal level. Our patients have found both freedom from pain and improved quality of life. Our professional staff is uniquely composed of physicians/researchers in the Stem Cell, Anti-Aging research and regenerative medicine, also including sports-related injuries and chronic joint pain.

For additional information visit


This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Investor Relations Contact

Andrew Barwicki

516-662-9461 /

Company Twitter: @Springsavra